SCHEMBL8400632

SCHEMBL8400632

CN(C)CCCN(C)c1ccc(N=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
TP53 P04637 1/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53
HIF1A Q16665 1/20 0.53
HSD17B10 Q99714 1/20 0.53
MMP14 P50281 1/20 0.40
MAPT P10636 1/20 0.40
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
CACNA1B Q00975 1/20 0.35
LMNA P02545 1/20 0.33
CA12 O43570 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
SYK P43405 2/20 0.32
TERT O14746 1/20 0.32
HTR2A P28223 1/20 0.32
HRH1 P35367 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10772951 0.82 ALDH1A1 (0.50) ALDH1A1TP53TSHRMAPK1HIF1A
SCHEMBL61402 0.79 ALDH1A1 (0.55) ALDH1A1TP53TSHRMAPK1HIF1A
Hydrochloric Acid SCHEMBL11503465 0.78 MMP14 (0.61) ALDH1A1TP53TSHRMAPK1HIF1A
SCHEMBL5725482 0.77 P2RY6 (0.43) ALDH1A1HSD17B10MMP14MAPTADRA2A
SCHEMBL20180579 0.76 ALDH1A1 (0.46) ALDH1A1TSHRMAPTCA12CA2
SCHEMBL14279822 0.76 ALDH1A1 (0.61) ALDH1A1TP53TSHRMAPK1HIF1A
SCHEMBL5899291 0.75 MMP14 (0.51) ALDH1A1TP53TSHRMAPK1HIF1A
SCHEMBL22837856 0.75 SLC6A4 (0.41) ALDH1A1TSHRMAPTCACNA1BHTR2A
SCHEMBL3156561 0.75 ALDH1A1 (0.48) ALDH1A1TP53TSHRMAPK1MAPT
SCHEMBL1825553 0.74 CYP2A6 (0.53) ALDH1A1HSD17B10MAPTCACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES MTOR, RICTOR, PDPK1 ALDH1A1 2736/4885TP53 1311/4885TSHR 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.